Who
William E. Ford
Director
Company insider
Files Form 4 as: Director, BlackRock; Director, BlackRock; Director, IHS Markit; Director, Royalty Pharma; Director, NYSE Euronext; Director, Nymex Holdings; Director, NYSE Group; Director, Archipelago Holdings.
In numbers
- Trades disclosed
- 204
- Buys
- 11
- Sells
- 21
- Bought
- $48.5M
- Sold
- $1.6B
- Companies
- 8
- Companies where not an officer
- 8
- First trade
- 7 Mar 2006
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —34 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —37 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —37 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —38 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —38 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —214 at $0.00 | filing |
| 16 Jan 2026filed 21 Jan 2026 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —214 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —34 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —34 at $0.00 | filing |
| 30 Sep 2025filed 2 Oct 2025 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —31 at $0.00 | filing |
| 30 Jun 2025filed 2 Jul 2025 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —35 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —38 at $0.00 | filing |
| 16 Jan 2025filed 17 Jan 2025 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —250 at $0.00 | filing |
| 31 Dec 2024filed 3 Jan 2025 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —35 at $0.00 | filing |
| 30 Sep 2024filed 2 Oct 2024 | BLK BlackRockCapital Markets & Asset Management | SEC FORM 4 Code A | —34 at $0.00 | filing |
| 28 Jun 2024filed 2 Jul 2024 | BlackRock | SEC FORM 4 Code A | —42 at $0.00 | filing |
| 28 Mar 2024filed 1 Apr 2024 | BlackRock | SEC FORM 4 Code A | —39 at $0.00 | filing |
| 16 Jan 2024filed 18 Jan 2024 | BlackRock | SEC FORM 4 Code A | —300 at $0.00 | filing |
| 29 Dec 2023filed 3 Jan 2024 | BlackRock | SEC FORM 4 Code A | —40 at $0.00 | filing |
| 29 Sep 2023filed 3 Oct 2023 | BlackRock | SEC FORM 4 Code A | —50 at $0.00 | filing |
News
Royalty Pharma (NASDAQ:RPRX) and Aditxt (NASDAQ:ADTX) Financial ComparisonRPRX · themarketsdaily.com · 18 Oct 2026
0 headlines in the last 90 days name William E. Ford; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.